In distinction, IntralipidH therapy improved ROS manufacturing without having escalating mitochondrial leak in healthier hearts (Figure 5D)
We formerly determined the fatty acid intermediate palmitoylcarnitine as pivotal in IntralipidH-mediated cardioprotection in...